Half-year report · HY

Period2026-01-01 → 2026-06-30
Filed2026-08-07
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥1.22T2026-01-01 → 2026-06-30Cons.Revenue IFRS
Revenue¥2.43T2025-01-01 → 2025-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.14T2025-01-01 → 2025-06-30Cons.Revenue IFRS
Operating income¥129.0bn2026-01-01 → 2026-06-30Cons.Operating profit loss IFRS
Operating income¥68.7bn2025-01-01 → 2025-06-30Cons.Operating profit loss IFRS
Profit before tax¥150.9bn2026-01-01 → 2026-06-30Cons.Profit loss before tax IFRS
Profit before tax¥237.9bn2025-01-01 → 2025-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥83.8bn2025-01-01 → 2025-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥101.7bn2026-01-01 → 2026-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥147.5bn2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥52.8bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥116.1bn2026-01-01 → 2026-06-30Cons.Profit loss IFRS
Net income¥60.5bn2025-01-01 → 2025-06-30Cons.Profit loss IFRS
Total assets¥3.40Tat 2026-06-30Cons.Assets IFRS
Total assets¥3.49Tat 2025-12-31Cons.Assets IFRS
Total assets¥3.30Tat 2025-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥1.72Tat 2026-06-30Cons.Liabilities IFRS
Total liabilities¥1.90Tat 2025-12-31Cons.Liabilities IFRS
Net assets / equity¥1.68Tat 2026-06-30Cons.Equity IFRS
Net assets / equity¥1.60Tat 2025-12-31Cons.Equity IFRS
Net assets / equity¥1.41Tat 2025-06-30Cons.Equity IFRS
Net assets / equity¥1.53Tat 2024-12-31vCons.Equity IFRS
Equity (owners)¥1.36Tat 2026-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.29Tat 2025-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.12Tat 2025-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥168.1bnat 2026-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥125.3bnat 2025-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥132.4bnat 2025-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥118.6bnat 2024-12-31vCons.Cash and cash equivalents IFRS
Operating cash flow¥137.3bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥295.4bn2025-01-01 → 2025-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥67.3bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow¥53.7bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥185.0bn2025-01-01 → 2025-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥61.6bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥162.5bn2026-01-01 → 2026-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥110.5bn2025-01-01 → 2025-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥35.8bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥126.332026-01-01 → 2026-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥182.132025-01-01 → 2025-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥65.232025-01-01 → 2025-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥182.132025-01-01 → 2025-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥65.222025-01-01 → 2025-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio40.0%at 2026-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio36.8%at 2025-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio34.0%at 2025-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2026-01-01 → 2026-06-30¥46.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2026-01-01 → 2026-06-30¥12.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2026-01-01 → 2026-06-30¥33.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2026-01-01 → 2026-06-30−¥1.5bn
Reconciling Itemsreconcilingrevenue2026-01-01 → 2026-06-30−¥38.9bn
Reconciling Itemsreconcilingrevenue intersegment2026-01-01 → 2026-06-30−¥38.9bn
Reconciling Itemsreconcilingsegment profit2026-01-01 → 2026-06-30−¥34.2bn
Alcoholic Beveragesreportable segmentrevenue2026-01-01 → 2026-06-30¥519.1bn
Alcoholic Beveragesreportable segmentrevenue external2026-01-01 → 2026-06-30¥517.8bn
Alcoholic Beveragesreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥1.3bn
Alcoholic Beveragesreportable segmentsegment profit2026-01-01 → 2026-06-30¥62.1bn
Health Sciencereportable segmentrevenue2026-01-01 → 2026-06-30¥131.1bn
Health Sciencereportable segmentrevenue external2026-01-01 → 2026-06-30¥128.8bn
Health Sciencereportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥2.3bn
Health Sciencereportable segmentsegment profit2026-01-01 → 2026-06-30¥10.4bn
Non Alcoholic Beveragesreportable segmentrevenue2026-01-01 → 2026-06-30¥296.7bn
Non Alcoholic Beveragesreportable segmentrevenue external2026-01-01 → 2026-06-30¥294.9bn
Non Alcoholic Beveragesreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥1.8bn
Non Alcoholic Beveragesreportable segmentsegment profit2026-01-01 → 2026-06-30¥31.0bn
Pharmaceuticalsreportable segmentrevenue2026-01-01 → 2026-06-30¥263.6bn
Pharmaceuticalsreportable segmentrevenue external2026-01-01 → 2026-06-30¥263.5bn
Pharmaceuticalsreportable segmentrevenue intersegment2026-01-01 → 2026-06-30¥139m
Pharmaceuticalsreportable segmentsegment profit2026-01-01 → 2026-06-30¥60.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-06-30¥47.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-06-30¥14.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-01-01 → 2025-06-30¥32.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-06-30−¥591m
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-06-30−¥38.3bn
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-06-30−¥38.3bn
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-06-30−¥30.0bn
Alcoholic Beveragesreportable segmentrevenue2025-01-01 → 2025-06-30¥493.8bn
Alcoholic Beveragesreportable segmentrevenue external2025-01-01 → 2025-06-30¥492.6bn
Alcoholic Beveragesreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥1.2bn
Alcoholic Beveragesreportable segmentsegment profit2025-01-01 → 2025-06-30¥53.2bn
Health Sciencereportable segmentrevenue2025-01-01 → 2025-06-30¥129.7bn
Health Sciencereportable segmentrevenue external2025-01-01 → 2025-06-30¥127.2bn
Health Sciencereportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥2.5bn
Health Sciencereportable segmentsegment profit2025-01-01 → 2025-06-30¥8.6bn
Non Alcoholic Beveragesreportable segmentrevenue2025-01-01 → 2025-06-30¥273.4bn
Non Alcoholic Beveragesreportable segmentrevenue external2025-01-01 → 2025-06-30¥271.8bn
Non Alcoholic Beveragesreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥1.6bn
Non Alcoholic Beveragesreportable segmentsegment profit2025-01-01 → 2025-06-30¥29.5bn
Pharmaceuticalsreportable segmentrevenue2025-01-01 → 2025-06-30¥230.7bn
Pharmaceuticalsreportable segmentrevenue external2025-01-01 → 2025-06-30¥230.5bn
Pharmaceuticalsreportable segmentrevenue intersegment2025-01-01 → 2025-06-30¥156m
Pharmaceuticalsreportable segmentsegment profit2025-01-01 → 2025-06-30¥33.5bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 869
ItemContextValueUnit
Share based payment transactions ss IFRSInterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Share based payment transactions ss IFRSInterimDuration_OtherComponentsOfEquityIFRSMember-JPY
Share based payment transactions ss IFRSInterimDuration_EquityAttributableToOwnersOfParentIFRSMember171000000JPY
Share based payment transactions ss IFRSInterimDuration_NonControllingInterestsIFRSMember-JPY
Share based payment transactions ss IFRSInterimDuration171000000JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSInterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSInterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSInterimDuration_OtherComponentsOfEquityIFRSMember-JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSInterimDuration_EquityAttributableToOwnersOfParentIFRSMember88000000JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSInterimDuration_NonControllingInterestsIFRSMember65000000JPY
Changes in ownership interests in subsidiaries that do not result in loss of control ss IFRSInterimDuration153000000JPY
Transfer from other components of equity to retained earnings ss IFRSInterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSInterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSInterimDuration_OtherComponentsOfEquityIFRSMember599000000JPY
Transfer from other components of equity to retained earnings ss IFRSInterimDuration_EquityAttributableToOwnersOfParentIFRSMember-44000000JPY
Transfer from other components of equity to retained earnings ss IFRSInterimDuration_NonControllingInterestsIFRSMember-JPY
Transfer from other components of equity to retained earnings ss IFRSInterimDuration-44000000JPY
Transfer from retained earnings to share premium ss IFRSInterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Transfer from retained earnings to share premium ss IFRSInterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Transfer from retained earnings to share premium ss IFRSInterimDuration_OtherComponentsOfEquityIFRSMember-JPY
Transfer from retained earnings to share premium ss IFRSInterimDuration_EquityAttributableToOwnersOfParentIFRSMember-JPY
Transfer from retained earnings to share premium ss IFRSInterimDuration_NonControllingInterestsIFRSMember-JPY
Transfer from retained earnings to share premium ss IFRSInterimDuration-JPY
Total transactions with owners IFRSInterimDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Total transactions with owners IFRSInterimDuration_EffectivePortionOfCashFlowHedgesIFRSMember-JPY
Total transactions with owners IFRSInterimDuration_OtherComponentsOfEquityIFRSMember599000000JPY
Total transactions with owners IFRSInterimDuration_EquityAttributableToOwnersOfParentIFRSMember-64259000000JPY
Total transactions with owners IFRSInterimDuration_NonControllingInterestsIFRSMember-7797000000JPY
Total transactions with owners IFRSInterimDuration-72056000000JPY
Equity IFRSInterimInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember251601000000JPY
Equity IFRSInterimInstant_EffectivePortionOfCashFlowHedgesIFRSMember-117000000JPY
Equity IFRSInterimInstant_OtherComponentsOfEquityIFRSMember272979000000JPY
Equity IFRSInterimInstant_EquityAttributableToOwnersOfParentIFRSMember1361975000000JPY
Equity IFRSInterimInstant_NonControllingInterestsIFRSMember318698000000JPY
Equity IFRSInterimInstant1680673000000JPY
Profit loss before tax IFRSPrior1InterimDuration83761000000JPY
Profit loss before tax IFRSInterimDuration150855000000JPY
Depreciation and amortization ope cf IFRSPrior1InterimDuration50062000000JPY
Depreciation and amortization ope cf IFRSInterimDuration54424000000JPY
Impairment losses reversal of impairment losses ope cf IFRSPrior1InterimDuration674000000JPY
Impairment losses reversal of impairment losses ope cf IFRSInterimDuration9439000000JPY
Interest and dividend income ope cf IFRSPrior1InterimDuration-4103000000JPY
Interest and dividend income ope cf IFRSInterimDuration-6675000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1InterimDuration-19392000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSInterimDuration-20306000000JPY
Interest expenses ope cf IFRSPrior1InterimDuration4891000000JPY
Interest expenses ope cf IFRSInterimDuration6735000000JPY
Gain on sale of property plant and equipment and intangible assets ope cf IFRSPrior1InterimDuration-464000000JPY
Gain on sale of property plant and equipment and intangible assets ope cf IFRSInterimDuration-78000000JPY
Loss gain on sale and retirement of property plant and equipment and intangible assets ope cf IFRSPrior1InterimDuration807000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2025-12-31pass rounding
balance sheet identityconsolidated 2026-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2026-01-01/2026-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2026-01-01/2026-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2026-01-01/2026-06-30pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsconsolidated 2026-06-30pass